The possible relationship between onco/suppressor gene expression and carcinogen exposure in vivo: evaluation of a potential biomarker in preventive and predictive medicine.

An understanding of the molecular changes occuring during exposure to a carcinogen enhances the possibility of cancer prevention. Molecular genetic-biological screening methods offer the potential for early diagnosis of high-risk groups, and identification of specific signals, as a major step in primary prevention. Recent investigations have suggested that oncogene or oncosuppressor gene expression investigation at the RNA level is a proper and early molecular epidemiological biomarker of carcinogen exposure and a tool for risk assessment. This is one way by which the high-risk groups could be recognized. At the protein level, the investigation of gene expression is very useful in molecular diagnosis and in molecular pathology.